US2019101546A1PendingUtilityA1
Methods of treating stroke
Est. expiryMay 25, 2026(expired)· nominal 20-yr term from priority
A61P 43/00A61P 9/10A61P 7/04A61P 9/00A61P 25/00A61P 25/28C07K 16/2842A61K 2039/505G01N 2800/2871A61K 31/00G01N 33/6896A61K 38/193A61K 38/49
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods and compositions for treating stroke are disclosed.
Claims
exact text as granted — not AI-modified1 .- 22 . (canceled)
23 . A method of treating spinal cord injury (SCI) in a subject, the method comprising administering to the subject a VLA-1 antagonist in an amount effective to treat SCI.
24 . A method of treating spinal cord injury (SCI) in a subject, the method comprising administering to the subject an anti-VLA-1 antibody, or an antigen-binding fragment thereof.
25 . The method of claim 23 , wherein the SCI is selected from the group consisting of incomplete SCI, central cord syndrome, Brown-Sequard syndrome, anterior cord syndrome, conus medullaris syndrome and cauda equina syndrome.
26 . The method of claim 24 , wherein the anti-VLA-1 antibody, or antigen-binding fragment thereof, is a human, chimeric or humanized anti-VLA-1 antibody, or an antigen-binding fragment thereof.
27 . (canceled)
28 . A method of treating ischemia-reperfusion injury in a subject, the method comprising administering to the subject a blocking VLA-1 antibody, or antigen-binding fragment thereof, in an amount effective to treat the injury.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.